Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Blue Cross Blue Shield Of New Mexico / Fasenra Pen Benralizumab

Fasenra Pen Benralizumab — Blue Cross Blue Shield Of New Mexico

4 indications indexed for this drug.

Chronic Rhinosinusitis With Nasal Polyps Crswnp
View coverage criteria
Eosinophilic Granulomatosis With Polyangiitis Egpa
View coverage criteria
Hypereosinophilic Syndrome Hes
View coverage criteria
Severe Eosinophilic Asthma
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.